Convatec Group Plc Stock Performance
| CNVVF Stock | USD 2.95 0.10 3.51% |
The firm shows a Beta (market volatility) of -0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ConvaTec Group are expected to decrease at a much lower rate. During the bear market, ConvaTec Group is likely to outperform the market. ConvaTec Group Plc right now shows a risk of 4.09%. Please confirm ConvaTec Group Plc variance, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if ConvaTec Group Plc will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ConvaTec Group Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, ConvaTec Group is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 565.4 M | |
| Total Cashflows From Investing Activities | -206.5 M | |
| Free Cash Flow | 211.8 M |
ConvaTec |
ConvaTec Group Relative Risk vs. Return Landscape
If you would invest 310.00 in ConvaTec Group Plc on September 1, 2024 and sell it today you would lose (15.00) from holding ConvaTec Group Plc or give up 4.84% of portfolio value over 90 days. ConvaTec Group Plc is currently producing 0.0014% returns and takes up 4.0901% volatility of returns over 90 trading days. Put another way, 36% of traded pink sheets are less volatile than ConvaTec, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
ConvaTec Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ConvaTec Group's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as ConvaTec Group Plc, and traders can use it to determine the average amount a ConvaTec Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 3.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNVVF |
Estimated Market Risk
| 4.09 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ConvaTec Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ConvaTec Group by adding ConvaTec Group to a well-diversified portfolio.
ConvaTec Group Fundamentals Growth
ConvaTec Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of ConvaTec Group, and ConvaTec Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ConvaTec Pink Sheet performance.
| Return On Equity | 0.0486 | |||
| Return On Asset | 0.0354 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 6.84 B | |||
| Shares Outstanding | 2.04 B | |||
| Price To Earning | 47.32 X | |||
| Price To Book | 3.51 X | |||
| Price To Sales | 2.88 X | |||
| Revenue | 2.04 B | |||
| EBITDA | 406.2 M | |||
| Cash And Equivalents | 463.4 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 1.2 B | |||
| Debt To Equity | 0.85 % | |||
| Book Value Per Share | 0.78 X | |||
| Cash Flow From Operations | 305.9 M | |||
| Earnings Per Share | 0.04 X | |||
| Total Asset | 3.67 B | |||
About ConvaTec Group Performance
By analyzing ConvaTec Group's fundamental ratios, stakeholders can gain valuable insights into ConvaTec Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ConvaTec Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ConvaTec Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. The company was founded in 1978 and is headquartered in Reading, the United Kingdom. Convatec Group operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 10142 people.Things to note about ConvaTec Group Plc performance evaluation
Checking the ongoing alerts about ConvaTec Group for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for ConvaTec Group Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ConvaTec Group Plc had very high historical volatility over the last 90 days | |
| About 61.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investors.com: Infosys ADR Shows Improved Relative Strength Still Shy Of Benchmark |
- Analyzing ConvaTec Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ConvaTec Group's stock is overvalued or undervalued compared to its peers.
- Examining ConvaTec Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ConvaTec Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ConvaTec Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ConvaTec Group's pink sheet. These opinions can provide insight into ConvaTec Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ConvaTec Pink Sheet analysis
When running ConvaTec Group's price analysis, check to measure ConvaTec Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ConvaTec Group is operating at the current time. Most of ConvaTec Group's value examination focuses on studying past and present price action to predict the probability of ConvaTec Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ConvaTec Group's price. Additionally, you may evaluate how the addition of ConvaTec Group to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |